
Verginox 40 Injection
Marketer
Converge Biotech
Salt Composition
Enoxaparin (40mg)
Overview Verginox 40 Injection
ClotGuard 40 Injection is an anticoagulant medication employed to prevent and manage potentially harmful blood clots. This medication inhibits the growth of existing clots and hinders the development of new ones. It's also indicated for preventing venous thromboembolism, encompassing deep vein thrombosis and pulmonary embolism. Administration of ClotGuard 40 Injection is subcutaneous, performed by a healthcare professional; intramuscular injection is contraindicated. Dosage and treatment duration are individualized, considering factors such as the patient's health status, treatment response, specific condition, age, and weight. Continued use is crucial, even in the absence of noticeable symptoms, as it safeguards against future complications. Discontinuation can lead to clot formation. Patients should avoid activities that heighten bleeding or injury risk during treatment. Frequently reported side effects include injection site discomfort, hemorrhage, cephalalgia, thrombocytosis, respiratory difficulties, edema, anemia, pyrexia, diarrhea, and elevated liver enzymes. Intense headache may signal intracranial bleeding, while severe abdominal pain can indicate gastrointestinal bleeding. Bleeding, potentially subtle, presents a significant risk; monitor for signs and consult your physician regarding any concerns. Prior to commencing treatment, disclose any history of hypertension, diabetes, or recent cerebrovascular accident. The medication is contraindicated in the presence of active bleeding. Inform your doctor about all other medications being taken to ensure compatibility and safety. Patients with low body mass may exhibit an increased bleeding propensity, and alcohol consumption can augment the risk of gastrointestinal bleeding.
Uses of Verginox 40 Injection
Preventing and managing blood clot formation.
Major Benefits of Verginox 40 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Verginox 40 Injection:
- Bleeding
- Headache
- Low blood platelets
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Fever
- Injection site pain
- Breathing problems
- Edema (swelling)
- Diarrhea
How to use Verginox 40 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Verginox 40 Injection works:
Invix 40 Injection is an antithrombotic agent that inhibits specific coagulation factors, thereby suppressing clot formation and mitigating vascular obstructions.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Verginox 40 Injection lacks established safety data. Physician consultation is advised.
PregnancySAFE IF PRESCRIBED
The use of Verginox 40 Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
Using Verginox 40 Injection while breastfeeding is likely safe. Available data from human studies indicates minimal risk to the infant. The drug's presence in breast milk is negligible, resulting in insignificant exposure to the baby, and therefore posing no anticipated harm.
DrivingSAFE
Driving ability is typically unaffected by Verginox 40 Injection.
KidneyCAUTION
Patients with kidney impairment should use Verginox 40 Injection judiciously; dosage modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Verginox 40 Injection's use in individuals with hepatic impairment. Physician consultation is recommended. Patients with pre-existing liver conditions should use this medication with prudence.
What if you forget to take Verginox 40 Injection :
Omitting a scheduled dose of Verginox 40 Injection warrants immediate medical advice.
Facts to Know About Verginox 40 Injection
| Label | Value |
|---|---|
| Chemical Type | Low-molecular-weight heparin |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavior Class | Low-molecular-weight heparin (LMWH) |
